✨ 7 results found - Searched 23110 records in 4ms.
Tesis
Hubungan Ekspresi Hypoxia Inducible Factor-1alpha, Rasio Neutrofil-Limfosit dan Rasio Trombosit-Limfosit Terhadap Progression Free Survival Tiga Tahun Pasien Kanker Kolorektal Lokal Lanjut
2025 | BY Rahmat Cahyanur - Nur Rahadiani - Galuh Chandra Kirana Sugianto - Cleopas Martin Rumende- The Association ofHypoxia Inducible Factor-1 Alpha Expression, Neutrophil-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio with Three-Year Progression-Free Survival in Locally Advanced Colorectal Cancer Patients.
- Nomor Panggil T25477fk
Tesis
Hubungan antara Rasio Neutrofil Limfosit, Rasio Limfosit Monosit dan Tumor Associated Macrophage terhadap Progression Free Survival 1 tahun pasien kanker payudara stadium lanjut baru HR-Positif Her2-Negatif
2024 | BY SUKAMTO - Tantri Hellyanti - Wulyo Rajapto - M. Arman Nasution- Relationship between Neutrophil Lymphocyte Ratio, Lymphocyte Monocyte Ratio and Tumor Associated Macrophage to 1 -year Progression Free Survival of patients with de novo advanced breast cancer patients HR-Positive Her2- Negative.
- Nomor Panggil T24442fk
Tesis
Faktor – faktor yang Memengaruhi Progression Free Survival 2 tahun pada Kanker Kepala dan Leher
2020 | BY Larangga Gempa Benbella - Andhika Rachman - Cosphiadi Irawan - Arif Mansjoer- Factors that Influence 2 Years Progression Free Survival Among Head and Neck Cancer.
- Nomor Panggil T20094fk
Tesis
Perbandingan rejimen kemoterapi cisplatin-etoposide dengan cisplatin-docetaxel dalam hal kesintasan 2 tahun dan progression-free survivalpasien kanker paru stadium lanjut jenis non-small cell
2012 | BY Salman Paris Harahap - Noorwati Sutandyo - Cleopas Martin Rumende - Hamzah Shatri- Comparison of chemotherapy effect between cisplatin-etoposide and cisplatin-docetaxed in 2-year survival rate and progression free survival rate of advanced non-small cell lung cancer patients.
- Nomor Panggil T12376fk
Tesis
Kesintasan Pada Kanker Paru Karsinoma Bukan Sel Kecil Jenis Adenokarsinoma Dengan Mutasi Epidermal Growth Factor Receptor Yang Diterapi Dengan Tyrosin Kinase Inhibitor Selama ≥ 18 Bulan Dan Faktor-Faktor Yang Memengaruhinya Di Rumah Sakit Umum Pusat Persahabatan
2024 | BY Vira Weldimira - Sita Laksmi Andarini - Jamal Zaini- Survival in non-small cell carcinoma lung cancer of adenocarcinoma type with epidermal growth factor receptor mutation treated with tyrosine kinase inhibitors for ≥ 18 months and influencing factors at RSUP Persahabatan.
- Nomor Panggil T24614fk
Tesis
Analisis terapi afatinib pada adenokarsinoma paru dengan mutasi epidermal growth factor receptor (EGFR) di RSUP Persahabatan
2023 | BY Widya Angasreni - Sita Laksmi Andarini - Jamal Zaini- Therapy Analysis of afatinib in lung adenocarcinoma with epidermal growth factor receptor mutation (EGFR) at Persahabatan Hospital.
- Nomor Panggil T23185fk
Tesis
Efikasi Dan Toksisiti Kemoterapi Karboplatin-Vinorelbin Pada Pasien Kanker Paru Jenis Karsinoma Bukan Sel Kecil (KPKBSK) Stage Lanjut DI RSUP Persahabatan
2017 | BY Sita Laksmi Andarini - Jamal Zaini - Putu Ayu Diah Puspita Sari- Efficacy and Toxicity of Carboplatin-Vinorelbine Chemotherapy in advanced Non-small cell lung cancer (NSCLC) Patients at Persahabatan Hospital.
- Nomor Panggil T17357fk